ImmunityBio, Inc. (IBRX) Stock Analysis

Free AI-powered analysis and research for ImmunityBio, Inc. stock

Sector: Healthcare

Analyze ImmunityBio, Inc. (IBRX) Stock

ImmunityBio, Inc. (IBRX) is a leading company in the Healthcare sector. Use StockIQ's free analysis tool to get comprehensive insights into IBRX stock performance, technical indicators, and AI-powered trading recommendations.

Get instant AI-powered analysis including technical indicators, fundamental analysis, risk assessment, and trading insights for ImmunityBio, Inc. stock.

📰 Latest Update

Piper Sandler Keeps an Overweight Rating on ImmunityBio, Inc. (IBRX)

Tue, March 10, 2026 at 7:32 AM UTC 4 min read

Piper Sandler has maintained an Overweight rating on ImmunityBio, Inc. (IBRX), indicating a positive outlook for the company's stock. This endorsement suggests that analysts believe IBRX is positioned for growth, which could attract investor interest and potentially drive up the stock price. Investors may view this as a signal of confidence in ImmunityBio's future performance and ongoing developments in its pipeline.

Read full article →

Why Analyze ImmunityBio, Inc. (IBRX) with StockIQ?

• ✅ Free AI-powered analysis of ImmunityBio, Inc. (IBRX) stock
• ✅ Real-time technical indicators for ImmunityBio, Inc. stock
• ✅ Comprehensive risk assessment for IBRX
• ✅ No credit card required

People also watch